Evaluation of immune-related response criteria (irRC) in patients (pts) with advanced melanoma (MEL) treated with the anti-PD-1 monoclonal antibody MK-3475.

Author:

Hodi F. Stephen1,Ribas Antoni2,Daud Adil3,Hamid Omid4,Robert Caroline5,Kefford Richard6,Hwu Wen-Jen7,Gangadhar Tara C.8,Joshua Anthony M.9,Hersey Peter10,Weber Jeffrey S.11,Dronca Roxana Stefania12,Perrone Andrea Marie13,Gammage Linda14,Hille Darcy15,Xue Dahai14,Kang Soonmo Peter16,Chun Patrick17,Ebbinghaus Scot18,Wolchok Jedd D.19

Affiliation:

1. Dana-Farber Cancer Institute, Boston, MA

2. David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA

3. University of California, San Francisco, San Francisco, CA

4. The Angeles Clinic and Research Institute, Los Angeles, CA

5. Institut Gustave Roussy, Paris, France

6. Westmead Hospital and Melanoma Institute Australia, University of Sydney, Westmead, Australia

7. The University of Texas MD Anderson Cancer Center, Houston, TX

8. Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA

9. Princess Margaret Cancer Centre, Toronto, ON, Canada

10. University of Sydney, Sydney, Australia

11. Moffitt Cancer Center, Comprehensive Melanoma Research Center, Tampa, FL

12. Mayo Clinic, Department of Medical Oncology, Rochester, MN

13. Merck, West Point, PA

14. Merck & Co., West Point, PA

15. Merck & Co., North Wales, PA

16. Merck & Co, Inc, Rahway, NJ

17. Merck/MRL, Kenilworth, NJ

18. Merck & Co, Inc, North Wales, PA

19. Memorial Sloan Kettering Cancer Center, New York, NY

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Review of F-18 FDG PET/CT in Evaluating Response to Immunotherapy Treatment;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024

2. Tumour flare reaction in cancer treatments;Anti-Cancer Drugs;2019-10

3. Considerations for Clinical Translation of MG1 Maraba Virus;Methods in Molecular Biology;2019-09-05

4. Pseudoprogression in patients on immunotherapy;Medical Council;2019-06-24

5. A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder;Clinical Genitourinary Cancer;2019-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3